Cormorant Asset Management’s Tarsus Pharmaceuticals TARS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $12.2M | Sell |
|
|||||
|
2025
Q1 | $20.5M | Sell |
|
|||||
|
2024
Q4 | $27.7M | Hold |
|
|||||
|
2024
Q3 | $16.4M | Hold |
|
|||||
|
2024
Q2 | $13.6M | Sell |
|
|||||
|
2024
Q1 | $77.8M | Sell |
|
|||||
|
2023
Q4 | $45M | Sell |
|
|||||
|
2023
Q3 | $46.6M | Buy |
|
|||||
|
2023
Q2 | $25.7M | Hold |
|
|||||
|
2023
Q1 | $17.9M | Sell |
|
|||||
|
2022
Q4 | $25.5M | Sell |
|
|||||
|
2022
Q3 | $33.8M | Buy |
|
|||||
|
2022
Q2 | $27.4M | Buy |
|
|||||
|
2022
Q1 | $23.1M | Sell |
|
|||||
|
2021
Q4 | $31.6M | Sell |
|
|||||
|
2021
Q3 | $31.1M | Sell |
|
|||||
|
2021
Q2 | $43.9M | Sell |
|
|||||
|
2021
Q1 | $55.3M | Hold |
|
|||||
|
2020
Q4 | $70M | Buy |
|